Page last updated: 2024-09-04

ezetimibe and cyclin d1

ezetimibe has been researched along with cyclin d1 in 1 studies

Compound Research Comparison

Studies (ezetimibe)	Trials (ezetimibe)	Recent Studies (post-2010) (ezetimibe)	Studies (cyclin d1)	Trials (cyclin d1)	Recent Studies (post-2010) (cyclin d1)
2,484	563	1,465	10,885	70	5,157

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gong, YZ; Li, GY; Li, XL; Liao, DF; Luo, HD; Qin, L; Xie, XJ; Yang, YB; Yang, YX; Zheng, XL	1

Other Studies

1 other study(ies) available for ezetimibe and cyclin d1

Article	Year
Inhibition of smooth muscle cell proliferation by ezetimibe via the cyclin D1-MAPK pathway. Journal of pharmacological sciences, 2014, Volume: 125, Issue:3 Topics: Animals; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclin D1; Depression, Chemical; Ezetimibe; Male; MAP Kinase Signaling System; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Rats, Sprague-Dawley; Up-Regulation	2014

Article

Year

Inhibition of smooth muscle cell proliferation by ezetimibe via the cyclin D1-MAPK pathway.

Journal of pharmacological sciences, 2014, Volume: 125, Issue:3

Topics: Animals; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclin D1; Depression, Chemical; Ezetimibe; Male; MAP Kinase Signaling System; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Rats, Sprague-Dawley; Up-Regulation

2014